Operating Lease, Liability in USD of Immix Biopharma, Inc. from Q1 2024 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Immix Biopharma, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2024 to Q3 2025.
Immix Biopharma, Inc. Operating Lease, Liability for the quarter ending September 30, 2025 was $1.11M, a 1.59% increase year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Immix Biopharma, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$1.11M	+$17.3K	+1.59%	Sep 30, 2025	10-Q	2025-11-07
Q2 2025	$1.04M	-$48.4K	-4.43%	Jun 30, 2025	10-Q	2025-08-08
Q1 2025	$1.06M	-$34.3K	-3.14%	Mar 31, 2025	10-Q	2025-05-08
Q4 2024	$1.07M			Dec 31, 2024	10-Q	2025-11-07
Q3 2024	$1.09M			Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$1.09M			Jun 30, 2024	10-Q	2024-08-12
Q1 2024	$1.09M			Mar 31, 2024	10-Q	2024-05-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.